This is an analysis from a patient's
perspective. I am not saying I am right, but this is the way I read
the 2014 ADA guidelines.
Even though I have read the summary of changes, I still see little difference between the 2013 and 2014
guidelines. At least this year there are no claims that testing has
changed and apparently all the hoopla raised last year that resulted
in no change in testing supply needs by insurance will get no more
support. This just shows how much support people with diabetes will
receive from the ADA.
Some minor changes were made for
gestational diabetes diagnosis and more precise language was put in
place for retinopathy exams from 2 to 3 years down to every two
years. This is still too general for people above the age of 60. It
ought to be every year and more often if any retinopathy is detected.
Other than this, you may read the
summary of changes here. I would urge people to read the Medscape
article by Dr. Anne Peters here and she covers the evolution of the
ADA guidelines in more detail and while I can agree with her, I wish
she would have pointed out more weaknesses.
I will quote her response to blood
glucose testing for those of us on insulin. “Once you have
diagnosed a patient with diabetes, you need to set treatment goals
and make a treatment plan. That is fairly standard and is outlined in
the standards of care. Somewhat different in the new guidelines is
how often patients with diabetes should be monitoring their blood
sugar levels.
Patients who are on multiple daily
insulin injections or an insulin pump should be monitoring their
blood sugar levels as frequently as they need to; in general, this is
before meals and snacks, at bedtime, if they are going to drive, if
they feel hypoglycemic, and from time to time after eating to get a
sense of their postprandial glucose levels. The total is somewhere in
the range of 4-10 times (typically 6-8 times) daily.
This frequency is often at variance
with what patients are allowed in terms of test strips. I spend a
great deal of time trying to get my brittle, older patients with type
1 diabetes the coverage for enough strips. It is important to fight
for this because as they get older, people often develop more
episodes of hypoglycemia, and we want our patients to have enough
strips for testing.”
No one seems supportive of patients on
oral diabetes medications and for him or her to be able to
self-monitor their blood glucose levels. All anyone wants is to move
them over to stronger medications and then to insulin if they HbA1c's
trend upward. This may be the best course of treatment if they will
not change the blood glucose testing requirements and recommend
reduction of carbohydrates to a reasonable level.